Financhill
Back

AT&T Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
45

T
AT&T

Last Price:
18.65
Seasonality Move:
0.28%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.45
Seasonality Move:
3.65%
Sell
45
AT&T (T) is a Sell

Is AT&T a Buy, Sell or Hold?

  • The current AT&T [T] share price is $18.40. The Score for T is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • T is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

T Stock Price Chart

What is AT&T's stock price today?

  • The AT&T share price today is $18.40
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and T is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

T Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 65.73 Buy
Chaikin Money Flow: 48253866 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.38 - 18.14) Buy
Bollinger Bands (100): (16.72 - 17.72) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

T Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.88 Buy
20-day SMA: 17.86 Buy
50-day SMA: 17.26 Buy
200-day SMA: 16.53 Buy
8-day EMA: 18 Buy
20-day EMA: 17.83 Buy
50-day EMA: 17.5 Buy
200-day EMA: 16.94 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

AT&T Earnings Growth & T Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $0.06 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

AT&T Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):